Ligand Pharmaceuticals, Inc. (LGND)
281.22
-3.30
(-1.16%)
USD |
NASDAQ |
Aug 28, 09:50
Ligand Pharmaceuticals 30-Day Average Daily Volume : 258762.6 for Aug. 27, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| August 27, 2026 | 258762.6 |
| August 26, 2026 | 259942.8 |
| August 25, 2026 | 264731.6 |
| August 24, 2026 | 279787.3 |
| August 21, 2026 | 282703.6 |
| August 20, 2026 | 282571.6 |
| August 19, 2026 | 297377.2 |
| August 18, 2026 | 303170.4 |
| August 17, 2026 | 305470.2 |
| August 14, 2026 | 312264.7 |
| August 13, 2026 | 317962.9 |
| August 12, 2026 | 326835.6 |
| August 11, 2026 | 343470.3 |
| August 10, 2026 | 349162.0 |
| August 07, 2026 | 384455.1 |
| August 06, 2026 | 397704.2 |
| August 05, 2026 | 402875.6 |
| August 04, 2026 | 472913.1 |
| August 03, 2026 | 489258.6 |
| July 31, 2026 | 503185.9 |
| July 30, 2026 | 505942.3 |
| July 29, 2026 | 503851.1 |
| July 28, 2026 | 497261.7 |
| July 27, 2026 | 493716.1 |
| July 24, 2026 | 490254.6 |
| Date | Value |
|---|---|
| July 23, 2026 | 489029.4 |
| July 22, 2026 | 482964.0 |
| July 21, 2026 | 483420.3 |
| July 20, 2026 | 483826.2 |
| July 17, 2026 | 477653.2 |
| July 16, 2026 | 473609.6 |
| July 15, 2026 | 471722.6 |
| July 14, 2026 | 468807.3 |
| July 13, 2026 | 452290.3 |
| July 10, 2026 | 448313.0 |
| July 09, 2026 | 449688.4 |
| July 08, 2026 | 437662.2 |
| July 07, 2026 | 436437.4 |
| July 06, 2026 | 431015.5 |
| July 02, 2026 | 428044.1 |
| July 01, 2026 | 422397.2 |
| June 30, 2026 | 409798.5 |
| June 29, 2026 | 384758.3 |
| June 26, 2026 | 371820.0 |
| June 25, 2026 | 337406.5 |
| June 24, 2026 | 319137.7 |
| June 23, 2026 | 307648.7 |
| June 22, 2026 | 239374.0 |
| June 18, 2026 | 233524.7 |
| June 17, 2026 | 219385.9 |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Johnson & Johnson | 7.137M |
| Eli Lilly & Co. | 2.653M |
| Merck & Co., Inc. | 10.26M |
| Zevra Therapeutics, Inc. | 1.241M |
| Liquidia Corp. | 1.536M |